Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2002 6
2003 11
2004 11
2005 18
2006 13
2007 16
2008 10
2009 10
2010 8
2011 7
2012 6
2013 3
2014 6
2015 5
2016 3
2017 4
2018 8
2019 3
2020 10
2021 10
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Antiviral effect of peptoids on hepatitis B virus infection in cell culture.
Murayama A, Igarashi H, Yamada N, Aly HH, Molchanova N, Lin JS, Nishitsuji H, Shimotohno K, Muramatsu M, Barron AE, Kato T. Murayama A, et al. Among authors: shimotohno k. Antiviral Res. 2024 Mar;223:105821. doi: 10.1016/j.antiviral.2024.105821. Epub 2024 Jan 23. Antiviral Res. 2024. PMID: 38272318
Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus.
Yato K, Matsuda M, Fukano K, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Wakita T, Muramatsu M, Kato T, Suzuki R. Yato K, et al. Among authors: shimotohno k. Virus Res. 2023 Jan 2;323:199014. doi: 10.1016/j.virusres.2022.199014. Epub 2022 Nov 26. Virus Res. 2023. PMID: 36511290 Free PMC article.
Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen.
Washizaki A, Murayama A, Murata M, Kiyohara T, Yato K, Yamada N, Aly HH, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Goh Y, Ishii KJ, Yotsuyanagi H, Muramatsu M, Ishii K, Takahashi Y, Suzuki R, Akari H, Kato T. Washizaki A, et al. Among authors: shimotohno k. Nat Commun. 2022 Sep 5;13(1):5207. doi: 10.1038/s41467-022-32910-z. Nat Commun. 2022. PMID: 36064848 Free PMC article.
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro.
Gad SA, Sugiyama M, Tsuge M, Wakae K, Fukano K, Oshima M, Sureau C, Watanabe N, Kato T, Murayama A, Li Y, Shoji I, Shimotohno K, Chayama K, Muramatsu M, Wakita T, Nozaki T, Aly HH. Gad SA, et al. Among authors: shimotohno k. PLoS Pathog. 2022 Mar 21;18(3):e1009983. doi: 10.1371/journal.ppat.1009983. eCollection 2022 Mar. PLoS Pathog. 2022. PMID: 35312737 Free PMC article.
Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
Takemori T, Sugimoto-Ishige A, Nishitsuji H, Futamura Y, Harada M, Kimura-Someya T, Matsumoto T, Honma T, Tanaka M, Yaguchi M, Isono K, Koseki H, Osada H, Miki D, Saito T, Tanaka T, Fukami T, Goto T, Shirouzu M, Shimotohno K, Chayama K. Takemori T, et al. Among authors: shimotohno k. J Virol. 2022 Mar 9;96(5):e0168621. doi: 10.1128/JVI.01686-21. Epub 2022 Jan 5. J Virol. 2022. PMID: 34985994 Free PMC article.
162 results